Physicians with two academic institutions made their cases in dueling opinion pieces published in the American Journal of Roentgenology Wednesday. 

Rates of colorectal cancer are on the rise, most notably in younger adults, who have seen CRC diagnoses double over the last decade.

The Australian company offers Annalise Enterprise CXR, which leaders believe is the most comprehensive decision aid for X-ray reading, able to identify up to 124 findings. 

End-of-life decisions are often anything but easy. AI might be able to help. 

An international cluster of 117 researchers from 50 countries has arrived at a consensus on six principles that, in the team’s considered view, ought to guide the use of AI across healthcare worldwide. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

Though numerous web-based tools have been created to flag published works that appear suspicious for AI authorship, the performances of these tools has been inconsistent thus far. 

Many people with low bone mineral density are not aware of their condition because they fail to get screened through DXA or are not eligible due to age.